Vaginal Squamous Cell Carcinoma

subtype

Identifier: CI-CAN-00004235
Entity page: /cancer/vaginal-squamous-cell-carcinoma ↗
Edges: 14

Neighbours: 7 drugs7 trials
Drawn: 14 of 14 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,149 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Vaginal Squamous Cell Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived7 of 7
→ investigated in trials for	Cisplatinsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Vaginal Squamous Cell Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Atezolizumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants

Vaginal Squamous Cell Carcinoma studied in …STUDIED_INderived7 of 7
→ studied in	NCT07217171Phase 1 · recruiting A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas · condition mapped CURATED_BROADER · 7 trials mapped (6 active)	—	—	Vaginal Squamous Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03074513Phase 2 · active not recruiting Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors · condition mapped CURATED_BROADER · 7 trials mapped (6 active)	—	—	Vaginal Squamous Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07804966Phase 2 · not yet recruiting Sac-TMT in Vaginal and Vulvar Cancers · condition mapped CURATED_BROADER · 7 trials mapped (6 active)	—	—	Vaginal Squamous Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02466971Phase 3 · active not recruiting Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers · condition mapped CURATED_BROADER · 7 trials mapped (6 active)	—	—	Vaginal Squamous Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02595879Phase 1 · active not recruiting Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer · condition mapped CURATED_BROADER · 7 trials mapped (6 active)	—	—	Vaginal Squamous Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped CURATED_BROADER · 7 trials mapped (6 active)	—	—	Vaginal Squamous Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03452332Phase 1 · completed Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Metastatic Cervical, Vaginal, or Vulvar Cancers · condition mapped CURATED_BROADER · 7 trials mapped (6 active)	—	—	Vaginal Squamous Cell Carcinoma	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains